UBS Group AG - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,032,789
-48.8%
57,537
-42.1%
0.00%
-100.0%
Q2 2023$2,016,661
+12.1%
99,294
+0.6%
0.00%0.0%
Q1 2023$1,799,503
+45.6%
98,657
+65.1%
0.00%
Q4 2022$1,235,588
+19.0%
59,748
+50.5%
0.00%
Q3 2022$1,038,000
-47.5%
39,696
-49.2%
0.00%
-100.0%
Q2 2022$1,979,000
-67.7%
78,078
-59.7%
0.00%
-50.0%
Q1 2022$6,119,000
+2503.8%
193,879
+3237.0%
0.00%
Q4 2021$235,000
-67.9%
5,810
-72.3%
0.00%
Q3 2021$731,000
+276.8%
20,956
+196.7%
0.00%
Q2 2021$194,000
-84.8%
7,062
-84.4%
0.00%
Q1 2021$1,275,000
+12650.0%
45,414
+12141.0%
0.00%
Q4 2020$10,000
-89.1%
371
-90.1%
0.00%
Q2 2020$92,000
-68.5%
3,733
-82.3%
0.00%
Q1 2020$292,000
-32.6%
21,057
-50.9%
0.00%
Q4 2019$433,000
+91.6%
42,871
+72.7%
0.00%
Q3 2019$226,000
+391.3%
24,831
+330.0%
0.00%
Q2 2019$46,000
-68.3%
5,775
-57.1%
0.00%
Q4 2018$145,000
+353.1%
13,465
+491.1%
0.00%
Q3 2018$32,000
+357.1%
2,278
+276.5%
0.00%
Q2 2018$7,0006050.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders